Dexrazoxane shortage — CA supply status & alternatives

Dexrazoxane

ATC V03AF02

In supply · Australia

CardioxaneDexrazoxane For

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇫🇷 FR

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Dexrazoxane
Brand names	Cardioxane, Dexrazoxane For

ATC level 5	V03AF02

ATC level 4	V03AF

Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper

Controlled substance	No

Marketing-authorisation holders	HIKMA PHARMACEUTICALS USA INC., AuroMedics Pharma LLC, Gland Pharma Limited, JUNO PHARMACEUTICALS CORP.

Registrations on file	6

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~11 months

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

8 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Msn Laboratories Private LTDSterling Wisconsin LLCTapi Nl BVBiocare Pharmaceutical LTDGland Pharma LTDApitoria Pharma Private LTD+2 more

Manufacturing countries: India, United States, China · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇨🇦

Canada

HC · 3h ago

High

🇫🇷

France

ANSM · 5d ago

Medium

Recalls official enforcement reports

🇺🇸

Dexrazoxane Active Pharmaceutical Ingredient Packaged In Var

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

Verified timeline regulator events

🇫🇷 23 Apr 2026

medium reported

🇨🇦 6 Feb 2026

high reported

🇫🇷 12 June 2025

Shortage resolved

🇨🇦 15 Dec 2016

high reported

Sources official regulators

🇨🇦

verified 3h ago

verify ↗

🇫🇷

ANSM

verified 5d ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders6 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
Dexrazoxane	250mg/1	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Dexrazoxane	500mg/1	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
DEXRAZOXANE	—	kit	🇺🇸 US	AuroMedics Pharma LLC	Active
Dexrazoxane	500mg/50mL	injection	🇺🇸 US	Gland Pharma Limited	Active
Dexrazoxane	250mg/25mL	injection	🇺🇸 US	Gland Pharma Limited	Active
Dexrazoxane For	—	solution	🇨🇦 CA	JUNO PHARMACEUTICALS CORP.	Active

Mederti Drug Report

Generated 3 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.